Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration
about
Gender analysis of moxifloxacin clinical trialsComparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers.Efficient intermittent rifapentine-moxifloxacin-containing short-course regimen for treatment of tuberculosis in mice.Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosisShould moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis? An answer from a murine modelMoxifloxacin efficacy and vitreous penetration in a rabbit model of Staphylococcus aureus endophthalmitis and effect on gene expression of leucotoxins and virulence regulator factors.A randomized trial of the efficacy and safety of sequential intravenous/oral moxifloxacin monotherapy versus intravenous piperacillin/tazobactam followed by oral amoxicillin/clavulanate for complicated skin and skin structure infectionsA thorough QT study to evaluate the effects of therapeutic and supratherapeutic doses of delafloxacin on cardiac repolarization.High-performance liquid chromatography assay for moxifloxacin in brain tissue and plasma: validation in a pharmacokinetic study in a murine model of cerebral listeriosis.Moxifloxacin in the treatment of skin and skin structure infections.In vivo validation of the mutant selection window hypothesis with moxifloxacin in a murine model of tuberculosis.Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the RELIEF study.Evaluation of Moxifloxacin-induced Biochemical Changes in MiceRapid eradication of Listeria monocytogenes by moxifloxacin in a murine model of central nervous system listeriosisAssociation Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired PneumoniaSkin and skin structure infections: treatment with newer generation fluoroquinolones.Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.Weekly moxifloxacin and rifapentine is more active than the denver regimen in murine tuberculosisPharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.Dexamethasone as adjuvant therapy to moxifloxacin attenuates valve destruction in experimental aortic valve endocarditis due to Staphylococcus aureus.In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental modelP-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model.Outpatient management of cholesteatoma with canal wall reconstruction tympanomastoidectomy.
P2860
Q28538319-961570E4-A681-4040-A666-5C625C700935Q33980661-1411C79D-239F-4CC0-92AB-FF9FA711FC4EQ34077125-ED559146-DA39-4E0D-BA3B-DCF1753A0166Q34108091-230F2D7D-1D83-4B35-9F0F-222D064EFB94Q34290003-32B24E15-9E65-4E10-9EC9-C768F3F61F53Q34938184-ACDD8C7B-A53F-475C-AF07-DF29120C770FQ35328383-66C6DE95-909C-43B7-95A5-D49E942584F5Q35607841-C668C0C2-1638-4A30-8177-545BD8B789A7Q35909500-2184F63A-A844-44BA-9D81-68B78962C344Q35919259-157EE672-7177-4AE9-A4E9-ECC1A1F9D46AQ36313268-147CEE7A-AFEC-4F4E-88FD-54B3EA506616Q36592698-DFC56F44-091D-4863-AC2C-426DEADDF386Q36865298-D32A2390-AF11-4C7A-9ECC-980BCD49F2A1Q36870838-E988F773-A48D-45AF-AFA5-08DD1CE20312Q36991795-80E43F36-6E6A-446C-8CD0-AFB378C2DBB6Q37116838-676FBD9F-881D-4E98-BB9F-CE564BF6F872Q37190660-5D591573-D8CE-4678-A1E1-2323B3FA7F30Q37282694-A5201F4C-5EF8-4F7D-A11E-DC449EA8CDEAQ39478796-91C367FB-3E6F-491F-9992-DDB5678F45ABQ42082902-C34B86DC-360C-4A4B-8CEB-1BCD10F6A931Q42116070-56AEEE9B-CC05-43CE-BF7A-123D0F669947Q43075165-AFD65B1F-1F4D-470D-8439-841221A697D0Q47150724-B12754F4-E6FD-465C-B2C4-3E49A3C5B0B5
P2860
Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Pharmacokinetics and inflammat ...... or intravenous administration
@en
Pharmacokinetics and inflammat ...... or intravenous administration.
@nl
type
label
Pharmacokinetics and inflammat ...... or intravenous administration
@en
Pharmacokinetics and inflammat ...... or intravenous administration.
@nl
prefLabel
Pharmacokinetics and inflammat ...... or intravenous administration
@en
Pharmacokinetics and inflammat ...... or intravenous administration.
@nl
P2093
P2860
P1476
Pharmacokinetics and inflammat ...... or intravenous administration
@en
P2093
P2860
P304
P407
P577
1999-06-01T00:00:00Z